Anton Melnyk

Texas Oncology — United States

Medicine · Health Sciences

12h-index1.2kcitations40works0.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(11), PI3K/AKT/mTOR signaling in cancer(9), Conducting polymers and applications(6), Advanced Breast Cancer Therapies(6), Chronic Lymphocytic Leukemia Research(5)

Publications40 total

RINATABART SESUTECAN MONOTHERAPY IN PATIENTS WITH ADVANCED ENDOMETRIAL CANCER: PART F OF THE PHASE 1/2 RAINFOL™-01 STUDY
International Journal of Gynecological Cancer·2025
A PHASE 3, OPEN-LABEL RANDOMIZED TRIAL TO COMPARE RINATABART SESUTECAN VERSUS INVESTIGATOR'S CHOICE OF CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER: RAINFOL™-02 (ENGOT-OV86/GOG-3107)
International Journal of Gynecological Cancer·2025
(ENCORE) Rinatabart sesutecan for patients with advanced ovarian cancer: Results from dose expansion cohort B1 of phase I/II study
Gynecologic Oncology·2025· 1 cited
A phase 3, open-label, randomized study of rinatabart sesutecan (Rina-S) vs investigator’s choice (IC) of chemotherapy in patients with platinum-resistant ovarian cancer (PROC).
Journal of Clinical Oncology·2025· 1 cited
Geodetic Support for the Use of Natural Resources of Chernivtsi Region Using GIS
Grassroots Journal of Natural Resources·2024Open Access
Analysis of the geodetic support of the territory of the Dnistrovsky district of the Chernivtsi region
Scientific Herald of Chernivtsi University Geography·2023· 1 citedOpen Access
GIS-Based Mapping of Spatial Specificities of Population Migrations in War-Time Ukraine
Scientific Herald of Chernivtsi University Geography·2023· 1 citedOpen Access
The use of GIS technologies for the analysis of geodetic provision of the territory of the Dnistrovsky district of the Chernivtsi region
Scientific Herald of Chernivtsi University Geography·2023Open Access
Data from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i>-Mutant Cancers
2023Open Access
Supplementary Figures from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i>-Mutant Cancers
2023Open Access
Supplementary Tables from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i>-Mutant Cancers
2023Open Access
Supplementary Figures from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i>-Mutant Cancers
2023Open Access
Supplementary Methods from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i>-Mutant Cancers
2023Open Access
Supplementary Methods from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i>-Mutant Cancers
2023Open Access
Data from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i>-Mutant Cancers
2023Open Access
Supplementary Tables from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i>-Mutant Cancers
2023Open Access
Solid-State Electron Affinity Analysis of Amorphous Fluorinated Polymer Electret
The Journal of Physical Chemistry B·2020· 16 cited
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i> -Mutant Cancers
Clinical Cancer Research·2020· 38 citedOpen Access
Monitoring of horizontal displacements of the Prut River bed using geoinformation technologies
Scientific Herald of Chernivtsi University Geography·2019· 1 citedOpen Access
Polaron spin dynamics in high-mobility polymeric semiconductors
Nature Physics·2019· 65 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Dejan Juric(11), Philippe L. Bédard(11), Jasgit C. Sachdev(11), Timothy R. Wilson(11), Michael C. Wei(11), Cristina Saura(10), Valentina Gambardella(10), Vincent Ribrag(10), Raid Aljumaily(10), Lara Dunn(9), Helen Won(9), Heidi Savage(9), Maurizio Scaltriti(9), David M. Hyman(9), Surai Jones(9), Komal Jhaveri(8), X. Cynthia(8), Denis Andrienko(7), Matthew T. Chang(7), Manish R. Patel(7)